YS BIOPHARMA CO LTD (LSBPW)
Institutional ownership reported to the SEC as of Q2 2026, across 14 quarters.
1
Reporting holders
$3
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Ancora Advisors LLC | $3 | 5,050 | 0.00% | 14q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $3 | 5,050 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $18 | 5,050 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $50 | 10,050 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 2 | $32 | 10,050 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 18 | $213.6K | 4,874,514 | 1 | 0 | 1 | 9.3% |
| Q1 2025 | 17 | $178.3K | 3,828,064 | 1 | 0 | 1 | 11.5% |
| Q4 2024 | 17 | $364.5K | 3,871,602 | 1 | 0 | 1 | 10.9% |
| Q3 2024 | 21 | $323.2K | 3,895,673 | 2 | 0 | 4 | 23.1% |
| Q2 2024 | 23 | $509.9K | 4,974,913 | 0 | 1 | 3 | 20.5% |
| Q1 2024 | 25 | $406.4K | 5,128,790 | 3 | 2 | 3 | 15.2% |
| Q4 2023 | 28 | $228.4K | 5,781,260 | 2 | 1 | 2 | 14.5% |
| Q3 2023 | 28 | $284.6K | 6,088,293 | 0 | 0 | 2 | 14.7% |
| Q2 2023 | 29 | $346.5K | 6,154,917 | 3 | 0 | 2 | 16.1% |
| Q1 2023 | 25 | $710.2K | 4,489,124 | 24 | 0 | 0 | 1.7% |